본문 바로가기
KERD
논문KCI 등재

혈액내과 임상약사의 처방중재 활동 평가

Evaluation of Clinical Pharmacist’s Interventions in Hematology

0

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

Background : The significance of the pharmacist’s clinical role has been demonstrated through several studies, and its importance is further emphasized through medication therapy management in hematology. Although many hematology clinical pharmacists operate in various hospitals domestically and abroad, few studies have evaluated the value of the pharmacists’ prescription interventions. The only domestic study to analyze the prescription interventions by hematology clinical pharmacists was published in 2014. However, it does not use the current revised classification criteria. Thus, the purpose of this study was to re-examine the prescription interventions of hematology clinical pharmacists in the current clinical context. Methods : The details of drug-related interventions were studied among patients admitted to a hospital’s hematology department July 2018-June 2019. The intervention cases were analyzed using the Pharmaceutical Care Network Europe (PCNE) version 9.0 criteria to determine the type of prescription interventions, the cause of drug-related problems, and if accepted. The Overhage criteria was applied to assess the significance of the interventions. Results : A total of 394 cases of drug prescription intervention were identified for analysis. The study results revealed that the most prescription-mediated drugs were antiemetics (15.3%), followed by antibiotics (13.4%), and antifungal agents (10.2%). According to the PCNE, the most frequently observed prescription intervention was “Effect of drug treatment not optimal (36.3%)”. The most frequent cause for the prescription intervention was “No or incomplete drug treatment in spite of existing indication (31.3%)”. The prescription intervention was accepted in 68.5%, of which 94.7% had clinical significance. Conclusion : This study confirmed that the clinical pharmacist in hematology conducts various and clinically significant interventions which optimize patient care. Thus, the results affirmed the positive/health-promoting role of the clinical pharmacist and we expect such results to serve as a basis for increasing in awareness of the role and importance of the clinical pharmacist.

Abstract

Background : The significance of the pharmacist’s clinical role has been demonstrated through several studies, and its importance is further emphasized through medication therapy management in hematology. Although many hematology clinical pharmacists operate in various hospitals domestically and abroad, few studies have evaluated the value of the pharmacists’ prescription interventions. The only domestic study to analyze the prescription interventions by hematology clinical pharmacists was published in 2014. However, it does not use the current revised classification criteria. Thus, the purpose of this study was to re-examine the prescription interventions of hematology clinical pharmacists in the current clinical context. Methods : The details of drug-related interventions were studied among patients admitted to a hospital’s hematology department July 2018-June 2019. The intervention cases were analyzed using the Pharmaceutical Care Network Europe (PCNE) version 9.0 criteria to determine the type of prescription interventions, the cause of drug-related problems, and if accepted. The Overhage criteria was applied to assess the significance of the interventions. Results : A total of 394 cases of drug prescription intervention were identified for analysis. The study results revealed that the most prescription-mediated drugs were antiemetics (15.3%), followed by antibiotics (13.4%), and antifungal agents (10.2%). According to the PCNE, the most frequently observed prescription intervention was “Effect of drug treatment not optimal (36.3%)”. The most frequent cause for the prescription intervention was “No or incomplete drug treatment in spite of existing indication (31.3%)”. The prescription intervention was accepted in 68.5%, of which 94.7% had clinical significance. Conclusion : This study confirmed that the clinical pharmacist in hematology conducts various and clinically significant interventions which optimize patient care. Thus, the results affirmed the positive/health-promoting role of the clinical pharmacist and we expect such results to serve as a basis for increasing in awareness of the role and importance of the clinical pharmacist.

참고문헌 (14)

  1. Chan A, "Clinical pharmacy services and research for lymphoma patients at a cancer center", Journal of Oncology Pharmacy Practice, 19(1), pp.24~30 (2013)
  2. Blower P, "Drug–drug interactions in oncology : why are they important and can they be minimized", Critical reviews in oncology, 2005, pp.55(2), 117~142
  3. Liekweg A, "From oncology pharmacy to pharmaceutical care : new contributions to multidisciplinary cancer care", Supportive care in cancer, 12(2), pp.73~79 (2004)
  4. 유소현, "약사에 의한 항암처방 중재 분석 및 처방 오류 개선 효과", 병원약사회지, 29(2), pp.131~138 (2012), 한국병원약사회[DOI]
  5. Carreras E, "The EBMT Handbook. Hematopoietic stem cell transplantation and cellular therapies" (2019), Springer
  6. Kim MG, "Network analysis of drug-related problems in hospitalized patients with hematologic malignancies", Support Care Cancer, 26(8), pp.2737~2742 (2018)
  7. 김효정, "내과계 중환자실 팀활동을 통한 약사의 처방중재 활동 평가", 병원약사회지, 35(3), pp.319~330 (2018), 한국병원약사회[DOI]
  8. 정정원, "외과계 중환자실 약사의 처방중재효과 평가", 병원약사회지, 31(4), pp.908~918 (2014), 한국병원약사회[DOI]
  9. 정채린, "혈액종양환자에서의 약물관련문제 분석과 이에 대한 임상약사의 중재 가치 평가", pp.2014
  10. "The PCNE Classification V 9.02019" (2019)[URL]
  11. Overhage JM, "Practical, reliable, comprehensive method for characterizing pharmacists’ clinical activities", American Journal of Health-System Pharmacy, 56(23), pp.2444~2450 (1999)
  12. Knez L, "Evaluation of clinical interventions made by pharmacists in cancer services", Pharmaceutical journal, 280(7492), pp.277~280 (2008)
  13. Fernández-Llamazares CM, "Impact of clinical pharmacist interventions in reducing paediatric prescribing errors", Archives of disease in childhood, 97(6), pp.564~568 (2012)
  14. Gates PJ, "Preventable Adverse Drug Events Among Inpatients : A Systematic Review", Pediatrics, 142(3), pp.87~ (2018)

관련 논문AI추천

이 간행물의 다른 논문 (6건)